Attached files
file | filename |
---|---|
10-K - FORM 10-K - FYE DEC 31 2014 - N-VIRO INTERNATIONAL CORP | nvic10k2014.htm |
EX-32.2 - EXHIBIT 32.2 - CFO SECTION 906 - N-VIRO INTERNATIONAL CORP | nvic10k2014_ex32z2.htm |
EX-14.1 - EXHIBIT 14.1 - CODE OF ETHICS - N-VIRO INTERNATIONAL CORP | nvic10k2014_ex14z1.htm |
EX-31.2 - EXHIBIT 31.2 - CFO CERT - N-VIRO INTERNATIONAL CORP | nvic10k2014_ex31z2.htm |
EX-21.1 - EXHIBIT 21.1 - LIST OF SUBSIDIARIES - N-VIRO INTERNATIONAL CORP | nvic10k2014_ex21z1.htm |
EX-31.1 - EXHIBIT 31.1 - CEO CERT - N-VIRO INTERNATIONAL CORP | nvic10k2014_ex31z1.htm |
EX-32.1 - EXHIBIT 32.1 - CEO SECTION 906 - N-VIRO INTERNATIONAL CORP | nvic10k2014_ex32z1.htm |
EX-24.1 - EXHIBIT 24.1 - DIRECTOR POWER(S) OF ATTORNEY - N-VIRO INTERNATIONAL CORP | nvic10k2014_ex24z1.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-121439 and 333-36608) of our report dated April 15, 2015, relating to the consolidated financial statements of N-Viro International Corporation included in this Annual Report on Form 10-K for the years ended December 31, 2014 and 2013.
Our report described above contains an explanatory paragraph that states that the Companys recurring losses, negative cash flow from operations and net working capital deficiency raise substantial doubt about its ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
/s/ UHY LLP
UHY LLP
Farmington Hills, Michigan
April 15, 2015